![Michael Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kelly
Direktor/Vorstandsmitglied bei
PRIME MEDICINE, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Michael Anthony Kelly is the founder of Sentry Hill Partners LLC, founded in 2018, where the title held is President.
Current jobs include Independent Director at DMC Global, Inc. since 2020; Lead Independent Director at NeoGenomics, Inc. since 2020; Director at NeoGenomics Laboratories, Inc. since 2020; Independent Director at Prime Medicine, Inc. since 2021; and Director at Chroma Medicine, Inc. since 2023.
Former jobs include Director at Direct Relief; Independent Director at HOOKIPA Pharma, Inc. from 2019 to 2023; Independent Director at Aprea Therapeutics, Inc. from 2020 to 2022; Director at Hookipa Biotech AG from 2019 to 2024; Independent Director at Amicus Therapeutics, Inc. from 2020 to 2026; Senior Vice President-Global Business Services at Amgen, Inc. from 2014 to 2017; Vice President-Finance & Controller at Biogen, Inc. from 1998 to 2000; Chief Financial Officer at Tanox, Inc. from 2000 to 2003; Principal at Onyx Capital Management LLC; Chief Financial Officer & Vice President at The NutraSweet Co. from 1996 to 1998; Chief Financial Officer at Monsanto Life Sciences Co.; and Chief Financial Officer & Vice President-Finance at Nutrasweet Kelco Co. Ltd. from 1996 to 1998.
Education includes undergraduate studies at Florida A&M University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEOGENOMICS, INC. 0.06% | 01.06.2026 | 72’086 ( 0.06% ) | 758 345 $ | 31.05.2026 |
DMC GLOBAL INC. 0.32% | 13.05.2026 | 65’590 ( 0.32% ) | 446 668 $ | 31.05.2026 |
PRIME MEDICINE, INC. -.--% | 05.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Michael Kelly
| Unternehmen | Position | Beginn |
|---|---|---|
| NEOGENOMICS, INC. | Direktor/Vorstandsmitglied | 15.07.2020 |
| DMC GLOBAL INC. | Direktor/Vorstandsmitglied | 24.07.2020 |
| PRIME MEDICINE, INC. | Direktor/Vorstandsmitglied | 01.11.2021 |
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories for diagnosing cancer | Direktor/Vorstandsmitglied | 01.07.2020 |
Sentry Hill Partners LLC
 Sentry Hill Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a business services and consulting firm that specializes in life sciences transformation and management | Gründer | 01.01.2018 |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Direktor/Vorstandsmitglied | 27.09.2023 |
Ehemalige bekannte Positionen von Michael Kelly
| Unternehmen | Position | Ende |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 27.04.2026 |
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Develops new generation prophylactic and therapeutic vaccines | Direktor/Vorstandsmitglied | 18.11.2024 |
| HOOA PHARPAR | Direktor/Vorstandsmitglied | 07.04.2023 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Michael Kelly
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
DMC Global, Inc.
 DMC Global, Inc. Oilfield Services/EquipmentIndustrial Services Operates as a holding company with interest in designs, manufactures and distributes products utilized by the oil and gas industry & produces explosion-welded clad metal plates | Industrial Services |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
Tanox, Inc.
 Tanox, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody and pharmaceutical solutions used for the treatment of allergic diseases | Health Technology |
Onyx Capital Management LLC
 Onyx Capital Management LLC Investment ManagersFinance Onyx manages a multi-strategy fund of convertible bond and capital structure arbitrage opportunities. | Finance |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
The NutraSweet Co.
 The NutraSweet Co. Agricultural Commodities/MillingProcess Industries Manufactures sweetener products | Process Industries |
Florida A&M University
 Florida A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Direct Relief
 Direct Relief Miscellaneous Commercial ServicesCommercial Services Operates charitable organizations and provides medical services | Commercial Services |
Monsanto Life Sciences Co. | |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Develops new generation prophylactic and therapeutic vaccines | Health Technology |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories for diagnosing cancer | Health Services |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Sentry Hill Partners LLC
Sentry Hill Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates as a business services and consulting firm that specializes in life sciences transformation and management | Commercial Services |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
Nutrasweet Kelco Co. Ltd. |
Wählen Sie MarketScreener 
